Coin Information
Rank#11248
Rank#11248
GlaxoSmithKline Tokenized Stock (Reality)
rgsk
GlaxoSmithKline Tokenized Stock (Reality)
$ 49.84
0.76% (24h)
0.000607 BTC
1.63% (24h)
60,705 satoshies
rocketatl

Contract

Asset
1h
24h
7d
1m
1y
max
rgsk
-
-
-
-
-
-

GlaxoSmithKline Tokenized Stock (Reality) Price Statistics

Market Cap Rank
#11248
Market Cap
546.6183 $
Circulating Supply
10.96
Total Supply
10.96
Max Supply
-
Fully Diluted Valuation
$ 530.45
24 Hour Trading Vol
2,479.9221 $
24h Low / 24h High
0/0
All-Time High
50.73
-1.75%
23 September, 2026, (a month ago)
All-Time Low
46.14596534
8%
14 October, 2026, (6 days ago)

GlaxoSmithKline Tokenized Stock (Reality) Performance

Trading Pair
day
week
month
rgsk / usd
0.76%
5.97%
-0.69%
rgsk / btc
1.63%
8.15%
-2.54%
rgsk / eth
1.58%
11.4%
6.32%

About Coin

GSK engages in the scientific R&D and commercialized production of prescription drugs and vaccines. The core business focuses on infectious disease prevention, immuno-inflammatory regulation, respiratory system diseases, and oncology treatments. The company screens active compounds in laboratories and advances human clinical validation, subsequently scaling up preparation in biochemical factories. Approved pharmaceutical and vaccine products are sold through formal supply chains to medical institutions and government procurement agencies across various countries.

What is the highest value GlaxoSmithKline Tokenized Stock (Reality) (RGSK) has ever reached?

GlaxoSmithKline Tokenized Stock (Reality) (RGSK) reached its peak price at 50.73 $ on 23 September 2026, approximately a month ago. Presently, the current price is -1.75% lower than this all-time high.

What is the historical minimum price for GlaxoSmithKline Tokenized Stock (Reality) (RGSK)?

The minimum price reached for GlaxoSmithKline Tokenized Stock (Reality) (RGSK) was 46.1459 $, documented on 14 October 2026, more than 6 days ago. In comparison, the current price is 8%, it above this historical low.

What is the fully diluted valuation of GlaxoSmithKline Tokenized Stock (Reality) (RGSK)?

The fully diluted valuation (FDV) of GlaxoSmithKline Tokenized Stock (Reality) (RGSK) stands at $ 530.45. This figure reflects the maximum potential market capitalization, considering that the current circulating supply is at its maximum of RGSK tokens. The realization of this FDV might take several years depending on the emission schedule of RGSK tokens.
IMPORTANT DISCLAIMER:   The information presented on our website and associated platforms is sourced from third parties and is intended for general informational purposes only. We do not guarantee the accuracy or timeliness of this content. None of the information provided should be construed as financial, legal, or other professional advice tailored to your specific needs. Your use of this content is at your own discretion and risk. It's important to independently research, evaluate, and verify the information before relying on it. Trading carries significant risks, so it's advisable to consult with a financial advisor before making any decisions. Our content is not intended to solicit or offer any services.
loader